ImmunityBio Inc - Common Stock — Cash Flow (NASDAQ:IBRX) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Cash from operating activities 70.5 M274.4 M337.5 M366.8 M391.2 M304.94 M 304.94 M Cash from investing activities 20.59 M84.89 M27.3 M30.47 M12.25 M149.8 M 149.8 M Cash from financing activities 86.97 M505.44 M233.61 M558.34 M281.63 M400.24 M 400.24 M Free cash flow 67.86 M240.84 M238.11 M336.22 M384.31 M300.68 M 301.09 M

新闻

ImmunityBio (IBRX)董事出售价值90万美元股票

Simon, director, sells ImmunityBio (IBRX) shares worth $900k

ImmunityBio完成膀胱癌试验患者招募

ImmunityBio completes enrollment in bladder cancer trial

ImmunityBio Investors Rally Behind Cancer Trial Milestone - ImmunityBio (NASDAQ:IBRX)

Netflix and Palantir among market cap stock movers on Wednesday

ImmunityBio Supersedes Expectations With Fivefold Revenue Increase - ImmunityBio (NASDAQ:IBRX)

ImmunityBio董事Selecky出售25万美元股票

ImmunityBio董事Simon, Barry J.出售价值178万美元股票

AMD and Keysight Technologies among market cap stock movers on Tuesday

Tesla, Oracle among market cap stock movers on Monday

H.C. Wainwright将Immunitybio目标价上调至15美元